Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | EVP | May 01, 2017 | May 04, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 01, 2017 · Filed May 04, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 102,516 |
Reported balance
After 2017-05-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-05-01 · Grant · Acquired 3,444 · Balance 102,516 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. F2: These shares include the following RSUs granted under the Company's equity plans: 1,601 RSUs which vest on 1/31/2018; 2,464 RSUs which vest in one installment of 1,213 on 1/30/2018 and one installment of 1,251 on 1/30/2019; 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020; and 3,444 RSUs which vest in installments of 1,136 on 5/1/2019, 1,137 on 5/1/2020 and 1,171 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3: These shares include 344 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $162.60 · Expires 2027-05-01 | Direct | 30,501 |
Reported balance
After 2017-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-05-01 · Grant · Acquired 30,501 · Balance 30,501 F4: This non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.
F2: These shares include the following RSUs granted under the Company's equity plans: 1,601 RSUs which vest on 1/31/2018; 2,464 RSUs which vest in one installment of 1,213 on 1/30/2018 and one installment of 1,251 on 1/30/2019; 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020; and 3,444 RSUs which vest in installments of 1,136 on 5/1/2019, 1,137 on 5/1/2020 and 1,171 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3: These shares include 344 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F4: This non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,200 | $81.45 | $97,740.00 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 12 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,600 Read SEC document |
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,112 | $81.44 | $90,561.28 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 11 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,800 Read SEC document |
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $81.42 | $8,142.00 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 10 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,912 Read SEC document |
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $81.41 | $32,564.00 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 9 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,012 Read SEC document |
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,600 | $81.40 | $130,240.00 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 8 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,412 Read SEC document |
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 900 | $81.39 | $73,251.00 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 7 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,012 Read SEC document |
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $81.38 | $32,552.00 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 6 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,912 Read SEC document |
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $81.37 | $81,370.00 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 5 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,312 Read SEC document |
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 17,762 | $81.36 | $1,445,116.32 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 4 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,312 Read SEC document |
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 44,168 | $68.58 | $3,029,041.44 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 3 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 48,000 | $61.67 | $2,960,160.00 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 20,000 | $38.36 | $767,200.00 |
DisclosureSEC source: 0001181431-05-061324 · rrd97235.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2005 Filed Aug 17, 2005 23:53 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 50,000 | $68.58 Strike: $68.58 | $3,429,000.00 |
DisclosureSEC source: 0001181431-05-047583 · rrd89850.xml · derivative · entry 8 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,168 Underlying: Common Stock · 50,000 shares Expires 2008-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2005 Filed Aug 17, 2005 23:53 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 38,046 | $80.50 | $3,062,703.00 |
DisclosureSEC source: 0001181431-05-047583 · rrd89850.xml · nonDerivative · entry 7 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,906 Read SEC document |
| August 16, 2005 Filed Aug 17, 2005 23:53 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,054 | $80.49 | $84,836.46 |
DisclosureSEC source: 0001181431-05-047583 · rrd89850.xml · nonDerivative · entry 6 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,952 Read SEC document |
| August 16, 2005 Filed Aug 17, 2005 23:53 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $80.17 | $80,170.00 |
DisclosureSEC source: 0001181431-05-047583 · rrd89850.xml · nonDerivative · entry 5 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,006 Read SEC document |
| August 16, 2005 Filed Aug 17, 2005 23:53 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,678 | $80.14 | $134,474.92 |
DisclosureSEC source: 0001181431-05-047583 · rrd89850.xml · nonDerivative · entry 4 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,006 Read SEC document |
| August 16, 2005 Filed Aug 17, 2005 23:53 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 500 | $80.11 | $40,055.00 |
DisclosureSEC source: 0001181431-05-047583 · rrd89850.xml · nonDerivative · entry 3 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,684 Read SEC document |
| August 16, 2005 Filed Aug 17, 2005 23:53 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 7,722 | $80.10 | $618,532.20 |
DisclosureSEC source: 0001181431-05-047583 · rrd89850.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,184 Read SEC document |
| August 16, 2005 Filed Aug 17, 2005 23:53 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 50,000 | $68.58 | $3,429,000.00 |
DisclosureSEC source: 0001181431-05-047583 · rrd89850.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 00:51 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017356 · rrd72676.xml · derivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2012-03-15 F1 · derivative.exercise_date: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006. Read SEC document |
| November 12, 2004 Filed Nov 16, 2004 16:58 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $38.36 | $0.00 |
DisclosureSEC source: 0001181431-04-053045 · rrd58060.xml · derivative · entry 3 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,394 Underlying: Common Stock · 20,000 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2004 Filed Nov 16, 2004 16:58 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 40,000 | $59.69 | $2,387,648.00 |
DisclosureSEC source: 0001181431-04-053045 · rrd58060.xml · nonDerivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,506 F1 · balance_after: (BMM-11-BQSO) The option becomes excercisable for 20,000 shares on July 1, 2003; 20,000 shares on July 1, 2004; 20,000 shares on July 1, 2005; 20,000 shares on July 1, 2006; and 17,394 shares on July 1, 2007, respectively. Read SEC document |
| November 12, 2004 Filed Nov 16, 2004 16:58 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 40,000 | $38.36 | $1,534,400.00 |
DisclosureSEC source: 0001181431-04-053045 · rrd58060.xml · nonDerivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P.,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (BMM-11-BQSO) The option becomes excercisable for 20,000 shares on July 1, 2003; 20,000 shares on July 1, 2004; 20,000 shares on July 1, 2005; 20,000 shares on July 1, 2006; and 17,394 shares on July 1, 2007, respectively. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 48,319 | $0.00 Strike: $59.84 | $0.00 |
DisclosureSEC source: 0001181431-04-015993 · rrd36864.xml · derivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P..Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,319 Underlying: Common Stock · 48,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.84 | $0.00 |
DisclosureSEC source: 0001181431-04-015993 · rrd36864.xml · derivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P..Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:21 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 98,482 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012801 · rrd11680.xml · derivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,482 Underlying: Common Stock · 98,482 shares Expires 2010-07-01 F2 · price: 0 F1 · derivative.exercise_date: (BMM-07/03-NQSO) The option becomes exercisable for 20,000 shares on July 1, 2004; 20,000 shares on July 1, 2005; 20,000 shares on July 1, 2006; 20,000 shares on July 1, 2007; and 18,482 shares on July 1, 2008, respectively. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:21 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,518 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012801 · rrd11680.xml · derivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 1,518 shares Expires 2010-07-01 F2 · price: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.